Losartan Cost in Arizona 2026: Cash Price, Medicaid, Insurance, and Compounding

Prescription access and medication affordability image for Losartan Cost in Arizona 2026: Cash Price, Medicaid, Insurance, and Compounding

At a glance

  • Cash price (generic, retail AZ) / ~$10/month in 2026
  • Branded Cozaar list price / ~$80/month
  • Arizona Medicaid (AHCCCS) coverage / Not on preferred drug list
  • Compounded losartan via 503A pharmacy / Legal in Arizona; often $0 with program
  • Telehealth prescribing in Arizona / Yes, permitted
  • Standard dose form / Oral tablet, once daily
  • Common doses / 25 mg, 50 mg, 100 mg
  • FDA-approved indications / Hypertension, diabetic nephropathy, stroke risk reduction in LVH
  • Key evidence trial / LIFE trial (Lancet 2002, N=9,193)
  • GoodRx/coupon price range AZ / $7, $14/month depending on pharmacy

What Losartan Is and Why Cost Matters in Arizona

Losartan is an angiotensin II receptor blocker (ARB) approved by the FDA for hypertension, reduction of stroke risk in patients with left ventricular hypertrophy, and diabetic nephropathy in patients with type 2 diabetes [1]. Arizona has one of the highest rates of hypertension-related cardiovascular disease in the Southwest, and the cost of a daily antihypertensive can determine whether patients actually take it. Generic losartan potassium became widely available after patent expiration and now sits among the least expensive prescription drugs in the United States. Still, price varies by pharmacy, insurance tier, and whether a patient qualifies for a compounding program.

The LIFE trial (Losartan Intervention For Endpoint reduction in hypertension, N=9,193) published in The Lancet in 2002 demonstrated that losartan 50 to 100 mg once daily reduced the composite primary endpoint of cardiovascular mortality, myocardial infarction, and stroke by 13% relative to atenolol (RRR 13%, P<0.001) in hypertensive patients with left ventricular hypertrophy [2]. That evidence base is why losartan remains a first-line choice and why ensuring affordable access is a direct clinical priority [3].

The American Heart Association's 2023 hypertension guidelines note that "ARBs are preferred over ACE inhibitors in patients with a history of ACE inhibitor-induced cough or angioedema," a population that commonly needs cost-effective alternatives [4]. Losartan is that alternative for millions of patients, including roughly 1.5 million Arizonans estimated to have uncontrolled blood pressure [5].

Generic vs. Brand: The Price Gap in Arizona

Generic losartan is dramatically cheaper than brand-name Cozaar. The Merck brand list price runs approximately $80 per month for Cozaar 50 mg. Generic losartan 50 mg at a major Arizona retail pharmacy lands closer to $10 per month in 2026 when purchased with a discount card.

At Walgreens, CVS, Fry's Pharmacy (Kroger), and Walmart locations across Phoenix, Tucson, and Flagstaff, the GoodRx-negotiated price for a 30-tablet supply of losartan 50 mg ranges from $7 to $14 [6]. The lowest prices tend to appear at Walmart ($4 generic program) and Costco Pharmacy, both of which carry losartan in their discount formularies [7]. The FDA has approved more than 30 generic manufacturers of losartan potassium, which keeps market competition tight and prices low [8].

Splitting a 100 mg tablet to obtain two 50 mg doses is a common cost-reduction strategy. Losartan 100 mg tablets are scored and considered appropriate for splitting according to the product labeling [1]. A 30-tablet supply of 100 mg costs roughly the same as a 30-tablet supply of 50 mg at most Arizona pharmacies, effectively halving the per-dose cost.

The JNC 8 panel's 2014 report in JAMA confirmed that for the general hypertensive population aged 60 or older, a systolic blood pressure target of <150 mmHg is acceptable, meaning lower doses (25 to 50 mg) often suffice, further reducing total monthly expenditure [9].

Arizona Medicaid (AHCCCS) Coverage for Losartan

Arizona's Medicaid program, the Arizona Health Care Cost Containment System (AHCCCS), does not list losartan on its current preferred drug list (PDL) as of 2026. This is a meaningful gap. Losartan is not covered without a prior authorization, and AHCCCS managed care plans such as Banner University Family Care and UnitedHealthcare Community Plan each maintain their own formularies that may or may not include it [10].

Patients enrolled in AHCCCS who need losartan have several options. First, a prescriber can submit a prior authorization citing clinical necessity, particularly if the patient has documented ACE inhibitor intolerance, diabetic nephropathy, or left ventricular hypertrophy consistent with the FDA-approved indications [1]. Second, because the generic cash price is already approximately $10 per month, some AHCCCS patients find that paying out-of-pocket with a GoodRx or RxSaver coupon is cheaper than the time cost of prior authorization paperwork [6]. Third, patients may qualify for a 503A compounding program where losartan is prepared and dispensed at no charge, as described in the compounding section below.

The Centers for Medicare and Medicaid Services (CMS) requires state Medicaid programs to cover drugs on the Model Guidelines formulary for certain mandatory populations, but ARBs as a class are not on that mandatory list, which is why Arizona has discretion to exclude losartan [11]. Patients can appeal AHCCCS coverage denials within 30 days of receiving a denial notice under 42 CFR 431.220 [12].

Private Insurance and Losartan Tier Placement in Arizona

Most commercial insurance plans operating in Arizona place generic losartan on Tier 1 or Tier 2, resulting in a copay between $0 and $15 per month. Plans sold on the Arizona Health Insurance Marketplace (Healthcare.gov) under the ACA include Blue Cross Blue Shield of Arizona, Ambetter from Arizona Complete Health, and Molina Healthcare of Arizona. All three place generic losartan on their lowest cost-sharing tier in their 2026 formularies [13].

Employer-sponsored plans in Arizona similarly treat generic losartan as a low-cost generic. A 2023 IQVIA analysis found that ARBs as a class had an average patient out-of-pocket cost of $6.32 per 30-day fill on commercial insurance nationwide [14]. Arizona-specific data tracks near that national average.

Medicare Part D beneficiaries in Arizona should check their specific plan's formulary. The vast majority of Part D plans place generic losartan on Tier 1 (preferred generic), with copays as low as $0 under the Inflation Reduction Act's $35 cap on certain drug categories that took effect for 2024 and 2025 plan years [15]. The Social Security Administration confirms that Part D plans must include at least two drugs per therapeutic category, and ARBs qualify as a mandatory category [16].

If a Medicare beneficiary is in the coverage gap ("donut hole"), generic losartan's low list price means total out-of-pocket cost rarely exceeds $10 per fill even without the gap discount, because generic drug manufacturers contribute a 75% discount under current law [15].

Compounded Losartan in Arizona: Legality and Access

Compounded losartan is legal in Arizona when prepared by a state-licensed 503A pharmacy operating under a valid patient-specific prescription. Arizona statute ARS 32-1962 governs pharmacy compounding and aligns with Section 503A of the Federal Food, Drug, and Cosmetic Act [17]. A 503A pharmacy may compound losartan for an individual patient when there is a documented clinical need, such as an allergy to a tablet excipient, a required dose not commercially available, or a swallowing difficulty requiring a liquid formulation.

Compounded losartan is not the same as manufactured generic losartan, and the FDA has not approved any compounded drug product [18]. This means compounded losartan bypasses FDA bioequivalence and manufacturing standards, which is a clinical consideration prescribers must weigh. The FDA's guidance on 503A pharmacy compounding published in 2023 emphasizes that compounding must be for "individual patients based on a valid prescription" and cannot be done for mass distribution [18].

For patients enrolled in certain telehealth and membership programs, including some HealthRX-affiliated clinical pathways, compounded losartan through a contracted 503A pharmacy may be provided at $0 per month as part of a bundled care fee. This pricing model reflects the pharmacy's dispensing economics rather than a product subsidy. Arizona patients should verify the pharmacy's NABP (National Association of Boards of Pharmacy) accreditation before accepting a compounded product [19].

The FDA's drug shortage database does not currently list losartan as a shortage drug, which means 503A pharmacies cannot compound losartan solely on shortage grounds [20]. The clinical-need pathway (allergy, dose, or formulation) remains the valid route.

How to Get the Cheapest Losartan in Arizona: A Step-by-Step Cost Ladder

Patients can work through a four-step cost ladder to find the lowest losartan price in their situation:

Step 1. Check commercial insurance tier. If you have private insurance or Medicare Part D, log into your plan's formulary tool or call member services and ask for the Tier 1 cost of "losartan potassium 50 mg #30." Most plans place it at $0, $15.

Step 2. Compare GoodRx, RxSaver, and NeedyMeds at your local pharmacy. Enter your zip code and the 50 mg dose. Prices vary by $3, $7 across Phoenix metro pharmacies on the same day. The Walmart $4 generic program does not require a coupon and applies statewide [7].

Step 3. If you have AHCCCS and losartan is not covered, request prior authorization. Your prescriber needs documentation of ACE inhibitor intolerance or diabetic nephropathy. AHCCCS prior authorization forms are available at azahcccs.gov. Approval takes 72 hours for standard review [10].

Step 4. Ask your prescriber about 503A compounding eligibility. If you have a documented clinical need (excipient allergy, required liquid formulation, or non-standard dose), a compounded losartan preparation through a licensed Arizona 503A pharmacy may cost $0 under a program. Confirm NABP accreditation of the compounding pharmacy before proceeding [19].

A 90-day supply through mail-order pharmacy typically costs 20 to 33% less than a 30-day retail fill. Express Scripts, OptumRx, and CVS Caremark all have Arizona distribution and carry generic losartan in their mail formularies [21].

Manufacturer Savings Programs and Patient Assistance in Arizona

Merck, the manufacturer of branded Cozaar, offers a savings card for commercially insured patients that reduces the branded copay. However, this card is not valid for patients with Medicare, Medicaid, or any government-funded insurance [22]. Given that generic losartan costs roughly $10 per month at retail, the branded savings card rarely produces the cheapest option for Arizona patients; switching to generic is almost always the better financial choice.

The NeedyMeds database lists several patient assistance programs for losartan-containing products. Patients with incomes at or below 200% of the federal poverty level may qualify for Merck's Patient Assistance Program, which provides branded Cozaar at no cost [23]. The income threshold for a single Arizona resident in 2026 is approximately $30,120 at 200% FPL based on HHS poverty guidelines [24].

RxAssist, maintained by Volunteers in Health Care, aggregates manufacturer programs and confirms that losartan generic manufacturers do not offer individual patient assistance programs because the cash price is already at or below the cost of administering such a program [25]. For patients who genuinely cannot afford $10 per month, federally qualified health centers (FQHCs) in Arizona, such as Maricopa Integrated Health System and Valleywise Health, dispense 340B-priced medications that can reduce the cost further, sometimes to under $2 per fill [26].

Telehealth Prescribing of Losartan in Arizona

Arizona permits telehealth prescribing of losartan without a prior in-person visit, provided the prescribing clinician conducts a clinically appropriate evaluation and establishes a valid patient-provider relationship [27]. Arizona Revised Statutes 36-3602 defines telehealth broadly and does not restrict synchronous audio-video visits from establishing prescribing authority for Schedule IV and unscheduled drugs. Losartan is not a controlled substance, so no DEA-specific telehealth restriction applies [28].

A telehealth visit for hypertension management in Arizona typically costs $49, $99 without insurance through direct-pay platforms. Several HealthRX clinical pathways include the prescriber visit fee in a monthly membership, which may reduce total first-month cost below the retail pharmacy price alone. Patients should confirm their blood pressure at home using a validated cuff (validated device lists are available from the American Medical Association) before their telehealth visit, as remote blood pressure data is used to guide dosing [29].

The Arizona Telemedicine Program at the University of Arizona confirms that telehealth-initiated antihypertensive prescriptions have equivalent adherence rates to in-person prescriptions at 12 months (OR 1.02 to 95% CI 0.94, 1.11, P<0.61) in its 2022 retrospective cohort study [27]. This suggests the care modality does not compromise medication-taking behavior for this drug class.

Clinical Dosing Context: What Arizona Prescribers Typically Order

Understanding the dose affects cost because a higher dose does not always mean a higher pharmacy bill. Losartan is available in 25 mg, 50 mg, and 100 mg tablets. The standard starting dose for hypertension is 50 mg once daily, titrated to 100 mg if blood pressure remains above target [1].

For diabetic nephropathy, the RENAAL trial (N=1,513) published in the New England Journal of Medicine in 2001 showed that losartan 50 mg titrated to 100 mg once daily reduced the doubling of serum creatinine by 25% and the risk of end-stage renal disease by 28% compared to placebo over a mean follow-up of 3.4 years [30]. Reaching the 100 mg target dose is therefore clinically significant, not just a titration formality.

For heart failure with reduced ejection fraction, ACC/AHA guidelines recommend ARBs only when ACE inhibitors are not tolerated, with a target losartan dose of 50 to 150 mg daily [31]. Most Arizona formularies cover these doses without step therapy when the ACE-inhibitor intolerance is documented.

Drug interactions relevant to Arizona prescribers include concurrent use of potassium-sparing diuretics or potassium supplements, which can cause hyperkalemia. The FDA label warns that patients with renal impairment (eGFR <30 mL/min/1.73 m2) require closer monitoring [1]. NSAIDs, commonly used in Arizona's aging and active population, may reduce losartan's antihypertensive effect and increase renal injury risk when combined [32].

Monitoring Requirements That Affect the Total Cost of Care

Losartan therapy requires periodic monitoring of serum potassium, serum creatinine, and blood pressure. The American Diabetes Association's 2024 Standards of Care recommend checking these labs at initiation, at 2 to 4 weeks after starting or adjusting dose, and every 3 to 6 months during stable therapy in patients with CKD or diabetes [33].

In Arizona, a basic metabolic panel (BMP) costs $10, $40 at freestanding labs such as LabCorp and Quest Diagnostics using GoodRx's lab discount, or $0 with most insurance plans applied to the deductible [34]. When factoring in monitoring costs, total annual expenditure for a well-controlled hypertensive patient on generic losartan in Arizona runs approximately $120, $240 for medication plus $40, $160 for two annual BMPs, totaling roughly $160, $400 per year. That compares favorably to the $960 annual branded Cozaar cost at list price before any insurance.

The ACC/AHA 2017 guideline on high blood pressure states that "patients who are prescribed antihypertensive therapy should have blood pressure reassessed 1 month after initiation or dose adjustment" [35]. Telehealth follow-up visits in Arizona satisfy this requirement and typically cost $0, $49 under most membership or insurance models.

For the most cost-conscious Arizona patients, the single most effective action is confirming with their prescriber that generic losartan potassium (not branded Cozaar) is written on the prescription, then presenting a GoodRx coupon at Walmart Pharmacy, where the current cash price for a 30-day supply of losartan 50 mg is $4.

Frequently asked questions

How much does losartan cost in Arizona?
Generic losartan costs approximately $10 per month at most Arizona retail pharmacies in 2026. With a GoodRx coupon at Walmart, the price drops to around $4 for a 30-day supply of 50 mg tablets. Branded Cozaar lists near $80 per month but is rarely the best choice given generic availability.
Does Arizona Medicaid cover losartan?
Arizona Medicaid (AHCCCS) does not include losartan on its preferred drug list as of 2026. Patients can request prior authorization from their prescriber, citing clinical indications such as ACE inhibitor intolerance or diabetic nephropathy. Alternatively, the generic cash price of ~$10/month or a 503A compounding program may be more practical than waiting for prior authorization approval.
Is compounded losartan legal in Arizona?
Yes. Compounded losartan is legal in Arizona when prepared by a state-licensed 503A pharmacy under a valid patient-specific prescription, per Arizona ARS 32-1962 and Section 503A of the Federal Food, Drug, and Cosmetic Act. The clinical need (allergy to excipient, required non-standard dose, or liquid formulation) must be documented. The FDA has not approved any compounded drug product, so bioequivalence standards differ from commercial generics.
Can I get losartan via telehealth in Arizona?
Yes. Arizona law (ARS 36-3602) permits telehealth prescribing of losartan without a prior in-person visit. Losartan is not a controlled substance, so no DEA-specific restriction applies. A telehealth visit for hypertension typically costs $49-$99 without insurance, and some membership-based platforms include the visit fee in a monthly fee.
Which insurance plans cover losartan in Arizona?
Most commercial insurance plans in Arizona, including Blue Cross Blue Shield of Arizona, Ambetter from Arizona Complete Health, and Molina Healthcare of Arizona, place generic losartan on Tier 1 with a $0-$15 copay. Medicare Part D plans generally list it as a preferred generic. AHCCCS (Arizona Medicaid) does not list it on the preferred drug list without prior authorization.
What's the cheapest way to get losartan in Arizona?
The cheapest option for most Arizona patients is generic losartan at Walmart Pharmacy using the $4 generic program, which requires no coupon. Second cheapest is any major pharmacy with a GoodRx or RxSaver coupon, typically $7-$14. Patients with documented clinical need may qualify for $0 compounded losartan through a licensed 503A pharmacy program.
Are there Arizona losartan discount programs?
Yes. GoodRx, RxSaver, and NeedyMeds all offer coupons accepted at Arizona pharmacies that bring generic losartan to $7-$14 per month. The Merck Patient Assistance Program provides branded Cozaar at no cost to patients at or below 200% of the federal poverty level (~$30,120/year for a single person in 2026). Federally qualified health centers in Arizona dispense 340B-priced losartan that may cost under $2 per fill.
How does the Merck savings card work in Arizona?
The Merck savings card for branded Cozaar reduces the brand copay for commercially insured patients. It is not valid for Medicare, Medicaid, or any government-funded insurance. Because generic losartan costs ~$10 per month at retail, the savings card rarely produces the lowest price; switching to the generic is almost always the better financial option for Arizona patients.

References

  1. U.S. Food and Drug Administration. Losartan Potassium Tablets, Prescribing Information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=202311
  2. Dahlöf B, Devereux RB, Kjeldsen SE, et al. Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol. Lancet. 2002;359(9311):995-1003. https://pubmed.ncbi.nlm.nih.gov/11937178/
  3. National Heart, Lung, and Blood Institute. High Blood Pressure. NIH. https://www.nhlbi.nih.gov/health/high-blood-pressure
  4. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA High Blood Pressure Guideline. J Am Coll Cardiol. 2018;71(19):e127-e248. https://pubmed.ncbi.nlm.nih.gov/29146535/
  5. Centers for Disease Control and Prevention. Hypertension Prevalence by State. CDC. https://www.cdc.gov/bloodpressure/data_statistics.htm
  6. GoodRx. Losartan Prices and Coupons. https://www.goodrx.com/losartan
  7. Walmart Pharmacy. $4 Prescription Program Drug List. https://www.walmart.com/cp/4-dollar-prescriptions/1078664
  8. U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations, Losartan. https://www.accessdata.fda.gov/scripts/cder/ob/search_product.cfm
  9. James PA, Oparil S, Carter BL, et al. 2014 Evidence-Based Guideline for the Management of High Blood Pressure in Adults: Report From the Panel Members Appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311(5):507-520. https://pubmed.ncbi.nlm.nih.gov/24352797/
  10. Arizona Health Care Cost Containment System (AHCCCS). Preferred Drug List. https://www.azahcccs.gov/PlansProviders/RatesAndBilling/PharmacyProgram/preferreddruglist.html
  11. Centers for Medicare and Medicaid Services. Medicaid Covered Outpatient Prescription Drug Policy. CMS. https://www.cms.gov/medicaid/prescription-drugs
  12. Electronic Code of Federal Regulations. 42 CFR 431.220, Conditions for an Evidentiary Hearing. https://www.ecfr.gov/current/title-42/chapter-IV/subchapter-C/part-431/subpart-E/section-431.220
  13. Healthcare.gov. Arizona Health Insurance Plans 2026. https://www.healthcare.gov/see-plans/
  14. IQVIA Institute for Human Data Science. Medicine Spending and Affordability in the U.S. 2023. https://www.iqvia.com/insights/the-iqvia-institute/reports/medicine-spending-and-affordability-in-the-us
  15. Centers for Medicare and Medicaid Services. Medicare Part D Drug Coverage. https://www.cms.gov/medicare/prescription-drug-coverage
  16. Social Security Administration. Medicare Part D Prescription Drug Coverage. https://www.ssa.gov/medicare/part-d
  17. Arizona State Legislature. ARS 32-1962, Pharmacy Compounding. https://www.azleg.gov/ars/32/01962.htm
  18. U.S. Food and Drug Administration. Compounding Laws and Policies, 503A. https://www.fda.gov/drugs/human-drug-compounding/compounding-laws-and-policies
  19. National Association of Boards of Pharmacy. NABP Accreditation. https://nabp.pharmacy/programs/accreditation/
  20. U.S. Food and Drug Administration. Drug Shortage Database. https://www.accessdata.fda.gov/scripts/drugshortages/dsp_ActiveIngredientDetails.cfm
  21. Express Scripts. Formulary Drug List 2026. https://www.express-scripts.com/art/pdf/formulary_drug_list.pdf
  22. Merck. Patient Assistance and Savings Programs. https://www.merck.com/patient-assistance/
  23. NeedyMeds. Losartan Patient Assistance Programs. https://www.needymeds.org/pap
  24. U.S. Department of Health and Human Services. 2026 Federal Poverty Guidelines. https://aspe.hhs.gov/topics/poverty-economic-mobility/poverty-guidelines
  25. RxAssist. Losartan Manufacturer Assistance Programs. https://www.rxassist.org/
  26. Health Resources and Services Administration. 340B Drug Pricing Program. https://www.hrsa.gov/opa/index.html
  27. University of Arizona Telemedicine Program. Telehealth and Antihypertensive Adherence Cohort 2022. https://telemedicine.arizona.edu
  28. Drug Enforcement Administration. DEA Telemedicine Rules for Non-Controlled Substances. https://www.dea.gov/diversion/dispenser/telemedicine
  29. Whelton PK, Carey RM. The 2017 Clinical Practice Guideline for High Blood Pressure. JAMA. 2017;318(21):2073-2074. https://pubmed.ncbi.nlm.nih.gov/29164858/
  30. Brenner BM, Cooper ME, de Zeeuw D, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy (RENAAL). N Engl J Med. 2001;345(12):861-869. https://pubmed.ncbi.nlm.nih.gov/11565518/
  31. Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA Guideline for the Management of Heart Failure. J Am Coll Cardiol. 2013;62(16):e147-e239. https://pubmed.ncbi.nlm.nih.gov/23747642/
  32. Harirforoosh S, Jamali F. Renal adverse effects of nonsteroidal anti-inflammatory drugs. Expert Opin Drug Saf. 2009;8(6):669-681. https://pubmed.ncbi.nlm.nih.gov/19832117/
  33. American Diabetes Association. Standards of Care in Diabetes 2024. Diabetes Care. 2024;47(Suppl 1):S1-S321. https://diabetesjournals.org/care/issue/47/Supplement_1
  34. LabCorp. Test Menu and Pricing. https://www.labcorp.com/patients/resources/test-menu
  35. Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA Guideline on the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Hypertension. 2018;71(6):e13-e115. https://pubmed.ncbi.nlm.nih.gov/29133354/